Table 2.
- | ± | + | ++ | P | ||
---|---|---|---|---|---|---|
Pathological grade | ||||||
Ⅰ | 2 | 14 | 34 | 4 | 0.009 | |
Ⅱ | 0 | 20 | 24 | 22 | ||
Ⅲ | 0 | 5 | 6 | 8 | ||
Gender | ||||||
Female | 0 | 0 | 9 | 22 | 13 | 0.253 |
Male | 1 | 2 | 31 | 44 | 18 | |
Age | ||||||
<50 | 1 | 0 | 0 | 3 | 1 | 0.768 |
50~60 | 2 | 0 | 16 | 25 | 11 | |
>60 | 3 | 2 | 24 | 38 | 19 | |
Clinical stage | ||||||
1 | 0 | 0 | 1 | 0 | 0.853 | |
2 | 1 | 17 | 24 | 9 | ||
3 | 1 | 23 | 41 | 22 |
* -: negative; ±:weak positive; +: positive; ++: strong positive